Big Pharma Has a Case of Merger Mania
It hasn’t been in many headlines (thanks, AI), but pharmaceutical companies are on a merger & acquisition spree that could break records. With more than $126 billion in deals so far this year, companies are looking for novel drug canddiates and clinical stage companies to bolster their own development pipeline. We’ll…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Motley Fool Hidden Gems Investing
See all episodes →Similar episodes from other shows
More like Motley Fool Hidden Gems Investing →
Big deals in Big Pharma
A Big Blue Breakup and a Money Manager Merger
Longevity: Can We Add Another 30 Years? | The Decade Ahead
Moderna's Cancer Vaccine Breakthrough & Why Uber Could Win the Robotaxi War
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.